TERT and central nervous system cancer: This group displays rare Tert promoter mutations (10 %); however, IDH1 and IDH2 mutations (75 %) as well as ATXR mutations (70 %) are common, which is also correlated with the high prevalence of ALT (63 %) in these gliomas.